The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

104Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

We studied the prognostic importance of tumor-infiltrating regulatory T lymphocytes (Tregs) and cytotoxic T/NK lymphocytes (CTLs) in 98 diagnostic biopsy specimens from patients with classical Hodgkin lymphoma (cHL). Immunohistochemical analysis was performed for FOXP3 to identify Tregs and for granzyme B (GrB) to identify activated CTLs. Failure-free survival (FFS) and overall survival (OS) were clinical end points. Patients with fewer than 25 FOXP3+ cells per high-power field (HPF) had a mean ± SD 5-year FFS of 64% ± 7% vs 85% ± 5% for patients with 25 or more FOXP3+ cells/HPF (P = .05). A FOXP3/GrB ratio of 1 or less was associated with poor FFS (46% ± 10% vs 86% ± 4%; P < .001) and OS (67% ± 10% vs 93% ± 3%; P

Cite

CITATION STYLE

APA

Kelley, T. W., Pohlman, B., Elson, P., & Hsi, E. D. (2007). The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. American Journal of Clinical Pathology, 128(6), 958–965. https://doi.org/10.1309/NB3947K383DJ0LQ2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free